Product
Fluticasone furoate + Umeclidinium bromide + Vilanterol trifenatate
Aliases
Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Name
Veramyst
INN Name
fluticasone furoate
FDA Approved
Yes
1 clinical trial
1 organization
1 indication
1 document
Indication
AsthmaClinical trial
A Phase 4, 52-week (Primary Analysis at 24-weeks), Randomized, Stratified, Open-label, Active-controlled, Parallel-group, Effectiveness Study, Comparing FF/UMEC/VI With Non-ellipta Usual Care (ICS/LABA) in Adult Participants With Uncontrolled AsthmaStatus: Not yet recruiting, Estimated PCD: 2026-03-11
Document
DailyMed Label: VeramystOrganization
Physicians Total Care, Inc.